Minocin IV
Total Payments
$11,003
Transactions
3
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $11,003 | 3 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,954 | 1 | 99.6% |
| Food and Beverage | $48.38 | 2 | 0.4% |
Payments by Type
Research
$10,954
1 transactions
General
$48.38
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NCT03160040 | Melinta Therapeutics, Inc. | $10,954 | 0 |
Ad
Manufacturing Companies
- Melinta Therapeutics, Inc. $11,003
Product Information
- Type Drug
- Total Payments $11,003
- Total Doctors 2
- Transactions 3
About Minocin IV
Minocin IV is a drug associated with $11,003 in payments to 2 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Melinta Therapeutics, Inc..
Payment data is available from 2019 to 2019. In 2019, $11,003 was paid across 3 transactions to 2 doctors.
The most common payment nature for Minocin IV is "Unspecified" ($10,954, 99.6% of total).
Minocin IV is associated with 1 research study, including "NCT03160040" ($10,954).